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Abstract: Feeding rats with high-fat diet (HFD) with a single streptozotocin (STZ) injection induced
obesity, slightly elevated fasting blood glucose and impaired glucose and insulin tolerance, and caused
cardiac hypertrophy and mild diastolic dysfunction as published before by Koncsos et al. in 2016.
Here we aimed to explore the renal consequences in the same groups of rats. Male Long-Evans rats
were fed normal chow (CON; n = 9) or HFD containing 40% lard and were administered STZ at 20
mg/kg (i.p.) at week four (prediabetic rats, PRED, n = 9). At week 21 blood and urine samples were
taken and kidney and liver samples were collected for histology, immunohistochemistry and for
analysis of gene expression. HFD and STZ increased body weight and visceral adiposity and plasma
leptin concentration. Despite hyperleptinemia, plasma C-reactive protein concentration decreased in
PRED rats. Immunohistochemistry revealed elevated collagen IV protein expression in the glomeruli,
and Lcn2 mRNA expression increased, while Il-1β mRNA expression decreased in both the renal
cortex and medulla in PRED vs. CON rats. Kidney histology, urinary protein excretion, plasma
creatinine, glomerular Feret diameter, desmin protein expression, and cortical and medullary mRNA
expression of TGF-β1, Nrf2, and PPARγ were similar in CON and PRED rats. Reduced AMPKα
phosphorylation of the autophagy regulator Akt was the first sign of liver damage, while plasma
lipid and liver enzyme concentrations were similar. In conclusion, glomerular collagen deposition
and increased lipocalin-2 expression were the early signs of kidney injury, while most biomarkers of
inflammation, oxidative stress and fibrosis were negative in the kidneys of obese, prediabetic rats
with mild heart and liver injury.
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1. Introduction
Obesity has a worldwide epidemic with a rapidly increasing incidence affecting more than
600 million patients [1]. The burden of obesity is magnified by the various secondary diseases that
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can develop in obese individuals e.g.,: Non-alcoholic steatohepatitis [2], heart failure with preserved
ejection fraction [3], as well as obesity-related glomerulopathy [4–7]. However, it is unpredictable which
disease will develop in a particular patient, and it is also unknown how long the obese state lasts before
the first co-morbidity symptoms appear in a patient. Furthermore, many obesity-related diseases can
accelerate each other’s progression [5,6], as in the case of hepatorenal syndrome [8]. This complicated
picture fuels much research effort to uncover the mechanisms as well as early diagnostic markers of
obesity-related co-morbidities.
The detailed mechanisms whereby obesity leads to co-morbidities are far from being understood,
but it seems likely that they are initiated by adipose tissue dysfunction. The main characteristics of
adipose tissue remodelling are increased production of adipocyte-derived proinflammatory cytokines
like leptin, TNFα, and IL-6 [9]. The consequent systemic low-grade inflammation has remote effects on
other organs including the kidneys [10]. Locally, lipid accumulation in different organs has been also
demonstrated, as a trigger of end-organ damage [11].
We performed a larger project, which evaluated first the general and cardiac effects of high-fat diet
(HFD) for 21 weeks with a low dose (20 mg/kg) of streptozotocin (STZ) at week four in Long-Evans
rats. According to the results published before, HFD increased body weight and body fat content,
and impaired glucose and insulin tolerance in comparison to the control (CON) rats, i.e., the animals
became prediabetic (PRED). The interventions caused cardiac hypertrophy and diastolic dysfunction
as a possible consequence of cardiac lipid accumulation and dysregulation of mitochondrial fusion and
mitophagy in myocytes leading to elevated oxidative stress in the heart. However, no dyslipidemia
and blood pressure changes were observed in PRED rats [12]. The aim of the current study was to
explore the renal consequences of obesity and prediabetic state in a part of the same rats, in order to
reveal early markers of obesity-related renal end-organ damage.
2. Results
2.1. Twenty Weeks of HFD with a Single Low-Dose of STZ Induced Obesity with Prediabetes, Adipose Tissue
Remodelling but Preserved Liver Function in Long-Evans Rats
During the 20 weeks follow-up period body weight increased in both groups. However, the body
weight of PRED animals was significantly higher, and body weight gain was greater from week
9 compared to the CON group. The difference in body weight between the two groups reached 46% at
week 20 (Figure 1A,B). At week 21 the relative epididymal fat tissue weight and plasma leptin levels
were significantly higher (Figure 1C,D), while, surprisingly, plasma CRP level was lower in the PRED
than in the CON group (Figure 1E).
Plasma triglyceride, cholesterol, low density lipoprotein (LDL) and high-density lipoprotein
(HDL) levels were similar in the groups (Figure 2A–D). In addition, we could not find any difference in
plasma concentrations of liver enzymes (glutamate oxaloacetate transaminase (GOT) and glutamate
pyruvate transaminase (GPT)) in the two groups (Figure 2E–F).
TGF-β1 mRNA expression was higher in epididymal and inguinal adipose tissues in the PRED
compared to the CON animals (Figure 3A). On the other hand, Nrf2, PPARγ and Adpn mRNA expression
was similar in both fat tissues in the two groups (Figure 3B–D). PPARγ and Adpn mRNA expression
was higher in the epididymal compared to the inguinal white adipose tissue (Figure 3C,D).
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Figure 1. Body weight, plasma and adipose tissue parameters at the end of the study. (A) Body weight
and (B) body weight gain of rats during the study in the two groups, (C) epididymal adipose tissue
weight (D) plasma leptin and (E) plasma CRP concentrations in obese prediabetic (PRED, grey columns)
and control (CON, white columns) rats at the end of the study. Data are means ± SEM, n ≥ 8/group.
Two-way RM ANOVA followed by Sidak’s post hoc test (A) and unpaired two-tailed Student’s t-test
(B-E); *: p < 0.05, **: p < 0.01; ***: p < 0.0001.
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Figure 2. Plasma concentrations of lipids and liver enzymes. (A) LDL cholesterol (mmol/L),
(B) total cholesterol (mmol/L), (C) plasma triglyceride (mmol/L), (D) HDL cholesterol (mmol/L),
(E), glutamate oxaloacetate transaminase (GOT; U/L) and (F) glutamate pyruvate transaminase (GPT;
U/L) concentrations in obese prediabetic (PRED, grey columns) and control (CON, white columns) rats
at the end of the study. Data are means ± SEM, n = 11/group. Unpaired two-tailed Student’s t-test.
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Figure 3. Gene-expression of adipose tissue remodelling indicators. (A) TGF-β1, (B) Nrf2, (C) PPARγ,
and (D) adiponectin (Adpn) mRNA expression in epididymal (epidAT) and inguinal white (ingWAT)
adipose tissues in obese prediabetic (PRED, grey columns) and control (CON, white columns) rats at
the end of the study. Data are means ± SEM, n ≥ 8/group. Two-way RM ANOVA; *: p < 0.05, **: p < 0.01;
***: p < 0.0001.
2.2. Renal Function was Preserved but Significant Glomerular Collagen Deposition and Tubular Lcn2
Expression Appeared in PRED Rats
Renal function was largely preserved in PRED rats despite obesity and hyperleptinemia. The renal
injury marker Lcn2 (NGAL) (mRNA expression) was 7.5-fold and 11.3-fold higher in the medulla and
cortex, respectively, in the PRED than in the CON group (Figure 4A). Urine Lcn2 (NGAL) levels were
similar in the two groups (Figure 4B). Plasma urea concentration was in the normal range in both
groups, but it was significantly lower in the PRED than in the CON group (Figure 4C). Plasma creatinine
concentration (Figure 4D) and urinary protein excretion (Figure 4E) were similar in PRED and CON rats.
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the two groups, excluding glomerular hypertrophy in PRED animals (Figure 5B). Relative PAS 
positive area of the glomerular tuft did not indicate pathologic accumulation of glomerular 
extracellular matrix (Figure 5C). Brush border of proximal tubular epithelial cells appeared normal 
and no inverse vacuolar staining was detectable. Oil-red-O staining, a specific marker for lipid 
accumulation, gave negative results in kidney samples of both the CON and PRED groups despite 
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Collagen IV staining increased significantly in the glomeruli of PRED rats compared to that in 
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Figure 4. Pa ameters of renal function and re i jury at the end of he study. (A) Lcn2 (NGAL)
mRNA expression in the kidney cortex and medulla, (B) urine Lcn2 excretion (C) plasma urea (mg/dL)
and (D) plasma creatinine concentrations (mmol/L), (E) urinary protein excretion in obese prediabetic
(PRED, grey columns) and control (CON, white columns) rats at the end of the study. Data are means ±
SEM, n ≥ 7/group two-way RM ANOVA (A); and unpaired two-tailed Student’s t-test (B-E); *: p < 0.05,
**: p < 0.01.
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Histological evaluation of PAS stained sections demonstrated intact kidney morphology in both
PRED and CON rats (Figure 5A). Average of maximum Feret diameter of glomeruli was similar in the
two groups, excluding glomerular hypertrophy in PRED animals (Figure 5B). Relative PAS positive
area of the glomerular tuft did not indicate pathologic accumulation of glomerular extracellular matrix
(Figure 5C). Brush border of proximal tubular epithelial cells appeared normal and no inverse vacuolar
staining was detectable. Oil-red-O staining, a specific marker for lipid accumulation, gave negative
results in kidney samples of both the CON and PRED groups despite significant lipid accumulation in
liver samples of PRED animals (Supplementary Figure S1).
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expressed to the same extent in PRED and CON kidneys. However, there were marked differences 
in favour of the medullary localization for both mRNAs irrespective of the diet. 
Expression of inflammation- and fibrosis-related microRNAs (miR-21, miR-29b, miR-192, miR-
200a, miR-200b) in the kidney was not significantly influenced in PRED compared to CON groups, 
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Figure 5. Kidney histology and immunohistochemistry. (A) Representative images of
periodic-acid-Schiff (PAS) stained glomeruli (left) and proximal tubuli (right) in CON (above) and PRED
rats (below). (B) The glomerular size indicator maximal Feret diameter; (C) PAS positive area relative
to total glomerular tuft area. (D) Representative images of collagen IV, alpha-smooth muscle actin
(αSMA) and desmin immunohistochemistry; (E) relative collagen IV positive and (F) desmin positive
area of the glomerular tuft in control (CON, left) and prediabetic (PRED, right) rats. Photos were taken
at 200x magnification; scale bar = 100 µm; data are means ± SEM, n = 9 samples/group, each data point
represents mean of 20 glomeruli/samples. Unpaired two-tailed Student’s t-test (B,C,E,F); *: p < 0.05.
Collagen IV staining increased significantly in the glomeruli of PRED rats compared to that in
CON rats (Figure 5D,E). The mesangial cell dedifferentiation nd activation marker, alpha smooth
muscle actin (αSMA) protein expression and the podocyte stress indicator desmin protein expression
appeared similar in the two groups (Figure 5D–F).
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2.3. Known mRNA and miRNA Markers of Renal Fibrosis were Unaffected in PRED Rats
TGF-β1 (Figure 6A) and the short-form of leptin-receptor (Ob-Ra) mRNAs (Figure 6B) were
expressed to the same extent in PRED and CON kidneys. However, there were marked differences in
favour of the medullary localization for both mRNAs irrespective of the diet.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 6 of 17 
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Figure 6. RNA and miRNA markers of fibrosis in the kidney. (A) TGF-β1 mRNA, (B) short-form
of leptin-receptor (Ob-Ra) mRNA expression and (C) expression of renal fibrosis arker icroRNAs
(miR-21, miR-192, miR-200a, miR-200b, and miR-29b) in the kidney cortex (c) and medulla (m) in obese
prediabetic (PRED, gray columns) and control (CON, white columns) rats at the end of the study. Data
are means ± SEM, two-way RM ANOVA, n = 8-9/group (A–C); n ≥ 4/group, expression of miRNAs is
presented relative to their cortical expression in CON (C). *: p < 0.05, **: p < 0.01; ***: p < 0.0001.
Expression of inflammation- and fibrosis-related microRNAs (miR-21, miR-29b, miR-192, miR-200a,
miR-200b) in the kidney was not significantly influenced in PRED compared to CON groups, although
significantly higher miR-21, miR-192 and lower miR-200b expression was detected in the kidney cortex
compared to the medulla (Figure 6C) regardless of the diet.
2.4. mRNA Expression of Inflammatory, Oxidative Stress, and Metabolic Markers in the Kidney in PRED Rats
To our surprise, IL-1β mRNA expression was strongly reduced both in the kidney cortex and
medulla (Figure 7A) in the PRED vs. the CON group, while TNFα mRNA expression was numerically
(by about 40%) but insignificantly reduced only in the kidney cortex (Figure 7B). Nrf2, PPARγ,
and HSP90β mRNA expression (Figure 7C–E) was not influenced in the PRED group. Marker genes of
inflammation (IL-1β, TNFα), oxidative stress (Nrf2) and metabolic impairment (PPARγ) were typically
expressed higher in the kidney medulla than in the cortex (Figure 7A–D).
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2.5. Phosphorylation of Akt on Ser473 was Reduced in PRED Rat Livers
Liver expression of autophagy-related proteins such as Beclin-1 and LC3-II was si ilar in the
two groups (Figure 8A,B). A PKα phosphorylation of Akt (an upstream odulator of autophagy) on
Ser473 was reduced in the liver lysates (Figure 8C), while the phosphorylation of AMPKα on Thr172 was
similar in the two groups (Figure 8D). Furthermore, the expression of a mitochondrial fusion-related
protein MFN2 (Figure 8E) and apoptosis-related cleaved-caspase-3 (Figure 8F) proteins was also similar
in the two groups.
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same groups of PRED rats as published recently [12]. These results [12] collectively suggest that 
Figure 8. Protein phosphorylation a d expression levels in the liver at the end of s udy. Representative
west rn blot prot in bands and r lative protein expression of (A) Beclin-1, (B) LC3, phosphorylated
(C) Akt and (D) AMPK, (E) and relative protein expression of MFN2 and (F) cleaved-caspase-3 in liver
sampl s of obes prediab tic (PRED, grey columns) and control (CON, white columns) rats at the end
of the study. Data are means ± SEM, n = 8/group. Unpaired two-tailed Student’s t-test. *: p < 0.05.
3. Discussion
The main finding of our study is that feeding Long-Evans rats with a HFD for 20 weeks and
administering a single low dose of STZ at week 4 lead to elevated glomerular collagen deposition and
caused tubular damage as demonstrated by increased cortical and medullary Lcn2 mRNA expression
but no other obvious kidney injury was observed. These mild renal effects were surprising as PRED
rats had higher body weight, body fat content and insulin resistance. The results of the cardiovascular
study performed in the same group of rats were published earlier [12]. Adipose tissue remodelling was
also present in PRED rats as evidenced by increased plasma leptin concentration and TGF-β1 mRNA
in both the inguinal and epididymal adipose tissues, as well as by elevated PPARγ and adiponectin
mRNA expression only in the epididymal adipose tissue. Furthermore, we had demonstrated hepatic
steatosis, left ventricular diastolic dysfunction and hypertrophy in the same groups of PRED rats as
published recently [12]. These results [12] collectively suggest that obesity with prediabetes caused
organ injury that started earlier in the adipose tissue, heart, and liver than in the kidney.
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Surprisingly, glomeruli of PRED rats had largely normal histomorphology. The average size of
glomeruli did not increase, ruling out glomerulomegaly—a hallmark of ORG, at this stage of the disease.
The relative PAS positive area of the glomerular tuft did not suggest accumulation of glomerular
extracellular matrix despite significantly elevated glomerular collagen IV protein deposition in the
glomerular basement membrane (GBM) of PRED rats. Accumulation of collagens, particularly types I,
IVα3, and IVα4 in the GBM is a typical phenomenon both in a non-diabetic, HFD fed mouse model of
obesity-related glomerulopathy (ORG) [13,14], and in a diabetic nephropathy model [15,16]. Increased
glomerular collagen IV protein deposition can be the direct consequence of elevated plasma glucose
in our study as high glucose leads to increased collagen IV synthesis in glomerular mesangial cells,
in vitro [17]. Glomerular collagen IV protein deposition can be considered as a very early sign of ORG.
An important hallmark of ORG is glomerular hyperfiltration as a consequence of vasodilation
of the afferent arteriole [18,19]. Preserved glomerular function, suggested by creatinine and urea
levels falling into the normal range, did not support glomerular hyperfiltration in our PRED rats, nor
did we observe any difference between the two groups in protein expression of desmin, an indicator
of podocyte stress [20]. It seems contradictory that plasma urea levels, generally used to monitor
renal excretory function, were decreased in PRED rats compared to that in CON animals. However,
in cafeteria-diet fed rodents hepatic synthesis of urea significantly decreased due to limited availability
of arginine [21,22]. Accordingly, lower plasma urea concentration in PRED rats can be due to decreased
urea synthesis in the liver, and does not necessarily indicate increased glomerular filtration in PRED
compared to CON animals in our study.
Increased cortical and medullary Lcn2 mRNA expression demonstrated tubular injury in PRED
rats. Thus, tubular injury also may be a very early event in ORG, later contributing to tubulointerstitial
fibrosis and CKD progression. Furthermore, early Lcn2 (NGAL) overproduction may accelerate CKD by
increasing inflammation [23,24], apoptosis and decreasing cell proliferation [25,26]. Thus, the observed
early Lcn2 production may be a trigger of later progressive renal damage in obesity.
Among the inflammatory cytokines IL-1β represents a central mediator of inflammation in various
tissues [27]. Surprisingly, both cortical and medullary IL-1β mRNA expression decreased in kidneys
of PRED compared to that of CON rats. It has been demonstrated previously that increased renal
and adipose tissue TNFα production is attributed to infiltrating pro-inflammatory macrophages
contributing to obesity-related renal impairment [28–30]. However, TNFα mRNA expression was
similar in the cortex and medulla in kidneys of PRED compared to that of CON rats. These results
collectively suggest that there was less inflammation in the kidneys in our model. Furthermore,
a somewhat decreased systemic inflammation was evident as plasma CRP levels decreased to a small
extent in PRED vs. CON rats [12].
Leptin—an adipose tissue hormone correlates with the amount of body fat, therefore, obesity is
accompanied with hyperleptinemia as also observed in our study [31]. The kidney expresses abundant
amounts of the small isoform of the leptin receptor (Ob-Ra) [32,33] Leptin infusion upregulated
glomerular TGF-β1 and collagen type IV expression in rats [34]. Therefore, leptin can be an important
contributor to obesity-induced kidney injury [35]. Plasma leptin increase was prominent in our study.
Thus, we hypothesized that leptin/Ob-Ra/TGF-β1 pathway could play a role in the elevated collagen
type IV accumulation in GBM of glomeruli in the PRED group. However, Ob-Ra and TGF-β1 expression
were similar in PRED and CON kidneys. Thus, chronically high plasma leptin alone was not sufficient
to induce ORG or renal tubulointerstitial fibrosis via Ob-Ra signalling in Long-Evans rats.
Although elevation of serum lipids (TG, total cholesterol, LDL, and HDL) was expected as a
consequence of extreme obesity, serum lipid and liver enzyme concentrations were within the reference
range and similar in PED and CON rats. There are some supporting results in the literature showing
that HFD did not increase total cholesterol in all rat studies [36]. Furthermore, it is known that some
obese patients have healthy lipid profile [37–39]. Thus, obesity likely leads to dyslipidemia, but not
necessarily in all obese subjects. The observed resistance of the Long-Evans strain to obesity-related
comorbidities is the most likely explanation for this lack of plasma lipid and liver-enzyme elevation.
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Therefore, our model offers a unique possibility to study the mechanisms of “obesity paradox” in
Long-Evans rats modelling those patients who remain healthy despite obesity. Strain differences are
not unusual in rats as we have shown previously concerning doxorubicin nephropathy.
Similarly to plasma lipids and liver enzymes, decreased plasma CRP concentration i.e., less
systemic inflammation is unusual in obese models. To our current knowledge this is the first paper
to report uncoupling excessive weight gain from inflammation. However, there is some supporting
data in the literature reporting that few individuals with BMI close to or above 30 can have low CRP
levels [40–42], thus, obesity does not necessarily cause inflammation in each individual. We hypothesize
that different response to the adipose tissue expansion and/or missing inflammatory mediators may be
responsible for this phenomenon.
The presence of intracellular lipid vacuoles is a characteristic finding in obesity both in rodent
models and in the kidney of obese patients, suggesting that abnormal lipid metabolism and lipotoxicity
may be the major cause of renal dysfunction [43–45]. In contrast to the heart and liver [12], renal
intracellular lipid accumulation was undetectable in PAS or oil-red-O stained (missing microvacuoles)
kidneys of PRED rats (see Supplementary Materials).
Limitations of the Study
A limitation of this study is that it was performed exclusively on male rats. Disease processes can
be substantially different in the two sexes (see NIH notice NOT-OD-15-102), e.g., female rats are less
susceptible to kidney injury than males. Since only mild kidney injury could be demonstrated in male
PRED rats it seems unlikely that we could draw a different conclusion in female rats.
Comparing our results to those published in the literature raises the question if Long-Evans rats
are similarly sensitive to diet-induced obesity and prediabetes in comparison to other rat strains or
HFD fed mouse models [46]. The majority of published results show that other rat strains develop ORG
after 20 weeks or even after 10 weeks of HFD. To our best knowledge there are no available results to
compare obesity-related co-morbidities in Long-Evans and other rat strains. Therefore, Long-Evans rats
seem to be more resistant to ORG than other rat strains. However, the relative resistance of Long-Evans
kidneys to obesity-related damage allowed us to study the order of injury development in various
organs in PRED Long-Evans rats. Furthermore, the Long-Evans rat could be a good model of “obesity
paradox”, as this strain can be used to identify the mechanisms of protection against obesity-related
co-morbidities. Such information can have therapeutic utility in the future.
The results of this study demonstrated that long-term HFD-induced obesity combined with
prediabetic metabolism was accompanied by collagen type IV accumulation in renal glomeruli and
enhanced tubular Lcn2 (NGAL) production in Long-Evans rats, but otherwise renal function and
morphology were preserved, while injury was observed in the heart and liver in the same animals.
The relative resistance of Long-Evans strain to develop renal injury due to obesity and prediabetes
is possibly attributable to reduced systemic and renal inflammation. The results seem to indicate
that obesity may harm the liver and the heart earlier than the kidney in prediabetic Long-Evans
rats fed a HFD. Thus, the Long-Evans rat strain may be suitable to study resistance mechanisms to
obesity-related glomerulopathy.
4. Materials and Methods
4.1. Animal Model and Experimental Setup
4.1.1. Ethics Statement
This investigation conforms to the Guide for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (Eighth Edition, 2011) and was approved (on 27. Dec. 2012.) by the
Animal Ethics Committee of the Semmelweis University (registration number: XIV-I-001/2103-4/2012).
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4.1.2. Animal Model
Male Long-Evans rats aging 5–7 weeks were purchased from Charles River Laboratories
(Wilmington, MA, USA). The animals were allowed free access to food and water ad libitum in
a room maintained on a 12 h–12 h light/dark cycle and at a constant temperature of 21 ◦C. After
1 week of acclimatization the rats were divided into two groups: control (CON; n = 20) and prediabetic
(PRED, n = 20). The control group was fed control chow, whereas the PRED group was fed a chow
supplemented with 40% lard as a HFD [12]. To facilitate the development of prediabetes the animals
on HFD received 20 mg/kg STZ (Santa Cruz Biotechnology, Dallas, TX, USA) intraperitoneally (i.p.)
at the fourth week according to Mansor et al. [47], whereas the control group was treated with the
same volume of citrate buffer as vehicle.
4.1.3. Renal Sample Collection
At week 21 the animals were anesthetized with pentobarbital (60 mg/kg, i.p.; Euthasol;
Produlab Pharma, Raamsdonksveer, The Netherlands) and underwent an extensive cardiac functional
examination protocol (including echocardiography and hemodynamic analysis described and published
earlier in detail [12]. From both groups 9 randomly selected rats were used to evaluate the renal effects
of HFD. Blood samples were collected by puncture of the abdominal aorta into EDTA-prefilled blood
collection tubes and the heart was removed in toto. Immediately upon these procedures the thoracic
aorta was ligated, and the carcass was perfused with 50–80 mL ice-cold physiological saline via an aortic
cannula inserted below the origin of the renal arteries. Application of sodium heparin or other systemic
anticoagulant was avoided as it was not allowed in the cardiac protocol. Eye-control assured complete
blood flush from the liver and the kidneys. The kidneys, liver, epididymal, and subcutaneous, inguinal
white adipose tissues were removed and weighed on an analytical balance. Small parts of the liver and a
1–2 mm horizontal sections of the left kidney were fixed in 4% buffered formaldehyde for 24 h, and then
were dehydrated and embedded in paraffin wax (FFPE) for histology and immunohistochemistry.
Similar pieces were embedded in Tissue Tek O.C.T. Compound (Sakura Finetech, Europe) and were
slowly frozen on dry ice for analysis of fat deposition. Kidney cortex and medulla samples from the
right kidney were separated by sterile surgical scalpel, sufficient pieces of liver and adipose tissue
samples were snap-frozen in liquid nitrogen in cryotubes and stored at –80◦C for molecular studies.
4.2. Analysis of Functional Kidney Parameters
Blood plasma was separated by centrifugation at 5000 rpf for 10 min, at 4 ◦C. Urine samples
were centrifuged at 5000× g for 5 min at 4 ◦C to remove the sediment, and then were stored at –80 ◦C
until analysis.
Plasma carbamide, plasma and urine creatinine concentrations were assessed using a colorimetric,
enzymatic assay (#9581C and #9571C respectively; Diagnosticum Ltd. Budapest, Hungary) in 96 well
plates (Greiner Bio-One GmbH, Frickenhausen, Germany).
Urine total protein concentration was assessed using a pyrogallol red colorimetric assay (#42051/DC,
Diagnosticum Ltd., Budapest, Hungary). The results were normalised to urine creatinine concentration.
Optical densities were measured at 598 nm (protein assay) and 555 nm (creatinine assay) in a SpectraMax
340 Microplate Reader (MolecularDevices, Sunnyvale, CA, USA). Concentrations were calculated
using SoftMax® Pro Software (Molecular Devices, Sunnyvale, CA, USA).
Plasma and urine lipocalin-2 (Lcn2) concentrations were measured using rat Lcn2/NGAL DuoSet
ELISA Development kit (R&D Systems, Minneapolis, MN, USA). Optical density was measured at
450 nm with wavelength correction set at 544 nm using Victor3 1420 Multilabel Counter (PerkinElmer,
WALLAC Oy, Turku, Finland). Concentrations were calculated using a four-parameter logistic curve-fit
(Work Out; Dazdaq Ltd., Brighton, England).
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4.3. Analysis of Renal Morphology
Routine histological and immunohistochemical analysis was performed on FFPE tissue samples.
Alterations in glomerular or tubulointerstitial morphology were evaluated in sections stained with
periodic-acid-Schiff (PAS).
4.4. Analysis of Plasma Lipid and Functional Liver Parameters
Plasma cholesterol, low density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride,
glutamate oxaloacetate transaminase (GOT), and glutamate pyruvate transaminase (GPT) were
measured by automated clinical laboratory methods (Diagnosticum, Budapest, Hungary). Plasma
leptin concentration was measured by ELISA (Invitrogen, Camarillo, CA, USA).
4.5. Immunohistochemistry
Paraffin sections mounted on Superfrost Ultra Plus Adhesion Slides (Thermo Fisher Scientific
Inc, Waltham, MA, USA) were deparaffinized and rehydrated in ethanol. Desmin, αSMA and
fibronectin immunohistochemistry was performed with polyclonal antibodies (anti-desmin MS 376-S1,
Thermo Fisher, 1:1000; anti- αSMA ab5694, Abcam, 1:1000; anti-FN HPA0027066, Atlas Antibodies,
1:1000), using the avidin–biotin method and developed by incubation with diaminobenzidine (Vector
Laboratories, Burlingame, CA, USA). Pictures were taken with Zeiss AxioCam 512 of the stained
sections for further analysis. Glomerular tuft was delineated manually and standard glomerulus size
parameters (e.g., Feret diameter) as wells as the PAS, desmin, and αSMA positive area were determined
using the CellProfiler cell image analysis software.
Lipid deposition was determined by oil-Red-O (O0625, Sigma-Aldrich, Budapest, Hungary)
staining of 5-µm-thick cryosections.
4.6. Gene-Expression Analysis of the Renal and Adipose Tissue Samples
4.6.1. RNA Preparation
Total RNA was extracted from the snap-frozen tissue samples (kidney, liver, adipose tissues)
with TRI Reagent® (Molecular Research Center, Inc., Cincinnati, OH, USA) according to the protocol
provided by the manufacturer [48]. In brief, the frozen renal tissues were homogenized by an IKA® DI
18 basic grinder (IKA® Works do Brasil Ltd.a., Taquora, Brazil). Chloroform (Sigma-Aldrich, Inc., St
Louis, MO, USA) was added to each sample and mixed by vortexing. The aqueous phase was separated
from the organic phase by centrifugation. RNA was precipitated from the transferred aqueous phase
with an equal quantity of isopropyl alcohol by incubation for 30 min at room temperature. The RNA
pellet was washed twice with 75% ethyl alcohol, and dissolved in 100 µL RNase free water. The RNA
concentration and purity was assessed with a NanoDrop 2000c Spectrophotometer (Thermo Fisher
Scientific, Wilmington, DE, USA). All RNA samples had an absorbance ratio (260 nm/280 nm) above
1.8. To check RNA integrity, the samples were electrophoresed on 1% agarose gel (Invitrogen Ltd.,
Paisley, UK) in BioRad Wide mini-sub® cell GT system (Bio-Rad Laboratories, Inc., Hercules, CA, USA),
and the ratio of 28S ribosomal RNA bands was calculated. The RNA solutions were kept at −80 ◦C
until further procedures.
4.6.2. Quantitative Real-Time PCR Analysis
Messenger RNA and miRNA levels in the kidney cortex or medulla and epididymal or inguinal
white adipose tissue samples were measured by double-stranded DNA (dsDNA) dye based real-time
PCR using Bio-Rad CFX96 Real Time System with a C1000 Thermal Cycler. Results were calculated
with the relative quantification (∆∆Cq) method, and the efficiency of the quantitative PCR reaction
was verified with standard curves.
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4.6.3. Messenger RNA Detection
First, reverse transcription of 1 µg total renal RNA into cDNA was carried out using random
hexamer primers and the High-Capacity cDNA Archive Kit (Applied Biosystem, USA) according
to the manufacturer’s protocol in Bio Rad iCycler™ Thermal Cycler (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). Second, in the real-time polymerase chain reaction (PCR) step, PCR products
were amplified from the cDNA samples using SensiFAST™ SYBR® No-ROX Master Mix (Bioline)
and target specific primer pairs to detect messenger RNA levels of adiponectin (Adpn), interleukine-1
beta (IL-1β), leptin receptor short-form (Ob-Ra), neutrophil gelatinase associated Lcn2 (NGAL), nuclear
factor (erythroid-derived 2)-like 2 (NFE2L2 or Nrf2), PPAR-gamma (PPARγ), tumor necrosis factor
alpha (TNFα), transforming growth factor β1 (TGF-β1) were used. Primers were self-designed by the
NCBI/Primer-BLAST online software and synthesized by Integrated DNA Technologies (IDT, Inc.,
Coralville, IA, USA), for detailed list of Fwd and Rev primer sequences see Table 1). All measurements
were done in duplicates. Target mRNA levels were normalized to Gapdh mRNA or to 28S rRNA levels.
Table 1. qPCR Primer Sequences.
Species Gene Symbol Primer Direction Sequence (5′->3′)
rno Adpn fwd 5′-AAAGGAGAGCCTGGAGAAGC-3′
rev 5′-GTCCCGGAATGTTGCAGTAG-3′
rno Gapdh fwd 5′-AACTTGCCGTGGGTAGAG-3′
rev 5′-ATGGTGAAGGTCGGTGTG-3′
rno IL-1β fwd 5′-AGA GTG TGG ATC CCA AAC AA -3′
rev 5′-AGT CAA CTA TGT CCC GAC CA -3′
rno Lcn2 fwd 5′-GATGTTGTTATCCTTGAGGCCC-3′
rev 5′-CACTGACTACGACCAGTTTGCC-3′
rno Nrf2 fwd 5′-CTC TCT GGA GAC GGC CAT GAC T-3′
rev 5′-CTG GGC TGG GGA CAG TGG TAG T-3′
rno Ob-Ra/532 fwd 5′-GACGATGTTCCAAACCCCAAG-3′
rev 5′-TGGGAGGTTGGTAGATTGGATTC-3′
rno PPARγ fwd 5′-CTGCCTATGAGCACTTCACAAG-3′,
rev 5′-ATCACGGAGAGGTCCACAGA-3′
rno TGF-β1 fwd 5′-AGCCCTGTATTCCGTCTCCT-3′
rev 5′-ATTCCTGGCGTTACCTTGG-3′
rno TNFα fwd 5′-TTCTCATTCCTGCTCGTGGC-3′
rev 5′-AACTGATGAGAGGGAGCCCA-3′
rno HSP90B fwd 5′-GGAAGCCCCCGCCCTCTGTATA-3′
rev 5′-AGGGCCAGTCAAGGCTGTTGG-3′
rno 28S fwd 5′-GGTAAACGGCGGGAGTAACT-3′
rev 5′-TCACCGTGCCAGACTAGAGT-3′
4.6.4. microRNA Detection:
Expression of microRNAs was evaluated with TaqMan probes (Chen et al., 2011). First,
complementary DNA (cDNA) was reverse-transcribed (RT) from 5 ng RNA sample using a
miRNA-specific, stem-loop RT primer (for miR-21, miR-29b, miR-192, miR-200a, miR-200b, and U6
snRNA) from the TaqMan® Small RNA Assays and reagents from the TaqMan® MicroRNA Reverse
Transcription Kit (Applied Biosystems™), as described in the manufacturer’s protocol. Second, in
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the real-time polymerase chain reaction (PCR) step, PCR products were amplified from the cDNA
samples using the TaqMan® Small RNA Assay together with the TaqMan® Universal PCR Master Mix
2. All measurements were done in duplicates, and the miRNA expressions were normalized to the U6
small nuclear RNA (snRNA) applied as an endogenous reference [49]. Since U6 expression levels were
found regulated in our model, the target microRNA levels were also normalized to the median of all
miRNA measurements Sq values, which didn’t reveal major differences in the final results.
4.7. Western Blot of Liver Lysates
Freeze clamped liver samples were pulverized under liquid nitrogen and homogenized in
homogenization buffer containing (in mmol/L): 20 Tris-HCl, 250 sucrose, 1.0 EGTA, 1.0 dithiothreitol,
or in radioimmunoprecipitation assay buffer (Cell Signaling Technology, Danvers, MA, USA),
supplemented with 1 mM phenylmethylsulphonylfluoride (PMSF; Roche, Basel, Switzerland), 0.1 mM
sodium fluoride, 200mM sodium orthovanadate and complete protease inhibitor cocktail (Roche) with
TissueLyser LT (Qiagen, Venlo, The Netherlands) to obtain liver whole cell lysate. Protein samples
were resolved on precast 4%–20% Criterion TGX gels (Bio-Rad, Hercules, CA, USA) and transferred
to nitrocellulose or Immun-Blot PVDF membranes (Bio-Rad). Quality of transfer was verified with
Ponceau S staining. Membranes were blocked with 5% nonfat milk (Bio-Rad) or 2%–5% bovine serum
albumin (BSA; Santa Cruz Biotechnology, Dallas, TX, USA) in Tris-buffered saline with 0.05% Tween
20 (TBS-T) for 0.5-2 h. Membranes were incubated with primary antibodies in 1%–5% nonfat milk
or BSA in TBS-T: anti-caspase-3 (1:500; Santa Cruz Biotechnology), anti-mitofusin-2 (MFN2; 1:2500,
Abcam, Cambridge, UK), anti-microtubule-associated protein 1 light chain 3 A/B (LC3 A/B; 1:5000),
anti-Beclin-1 (1:1000), anti-phospo-Akt (Ser473; 1:1000), anti-Akt (1:1000), anti-phospho-AMP-activated
protein kinase α (AMPKα-Thr172; 1:1000), anti-AMPKα (1:1000), and anti-GAPDH (1:5000) as loading
control (Cell Signaling Technology). After three washes with TBS-T, horseradish peroxidase conjugated
secondary antibody was added for 2 h at room temperature (1:5000 in 5% nonfat milk in TBS-T).
Signals were detected with an enhanced chemiluminescence kit (Bio-Rad, Hercules, CA) by Chemidoc
XRS+ (Bio-Rad). Antibodies against phosphorylated epitopes were removed with Pierce Stripping
Buffer (Thermo Fisher Scientific, Waltham, MA, USA) before incubation with antibodies detecting the
total protein.
4.8. Statistical Analysis
The results are presented as mean ± standard error of the mean (SEM) unless otherwise indicated.
Logarithmic transformation was performed if Bartlett’s test indicated inhomogeneity of variances.
Continuous variables were compared using either Student’s unpaired “t” test or two-way ANOVA
with Tukey’s multiple comparisons test. Body weight gain was analysed using two-way ANOVA for
repeated measurements (two-way RM ANOVA) followed by Sidak’s post hoc test. The null-hypothesis
was rejected if the p value reached statistical significance (*: p < 0.05, **: p < 0.01, ***: p < 0.001).
GraphPad Prism6 software (GraphPad Software, La Jolla, CA, USA) was used for data management,
statistical analysis and depicting figures.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/17/4266/s1.
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